NCT02395666 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 101
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 140
- units
- Participants
- groups
- description
- Subjects that are in remission at the end of upfront therapy defined as chemotherapy (5-7 cycles), surgery as indicated, consolidation therapy as indicated, radiation therapy as indicated, anti-GD2 antibody therapy with retinoic acid up to 6 cycles. Subjects will receive twenty-seven (27) cycles of oral DFMO at a dose of 500 to 1000 mg/m2 BID on each day of a 28 day cycle.
- id
- BG000
- title
- Stratum 1
- description
- Subjects that are in remission after any previous relapse or refractory therapy. Subjects will receive twenty-seven (27) cycles of oral DFMO at a dose of 500 to 1000 mg/m2 BID on each day of a 28 day cycle.
- id
- BG001
- title
- Stratum 2
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 1
- upper Limit
- 17
- value
- 4.4
- group Id
- BG001
- lower Limit
- 1
- upper Limit
- 14
- value
- 6.8
- group Id
- BG002
- lower Limit
- 1
- upper Limit
- 17
- value
- 5.1
- dispersion Type
- FULL_RANGE
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 44
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 55
- title
- Female
- measurements
- group Id
- BG000
- value
- 57
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 85
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 10
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 82
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 114
- title
- White
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 10
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 101
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 140
- units
- Participants
- groups
- description
- Subjects that are in remission at the end of upfront therapy defined as chemotherapy (5-7 cycles), surgery as indicated, consolidation therapy as indicated, radiation therapy as indicated, anti-GD2 antibody therapy with retinoic acid up to 6 cycles. Subjects will receive twenty-seven (27) cycles of oral DFMO at a dose of 500 to 1000 mg/m2 BID on each day of a 28 day cycle.
- id
- BG000
- title
- Stratum 1
- description
- Subjects that are in remission after any previous relapse or refractory therapy. Subjects will receive twenty-seven (27) cycles of oral DFMO at a dose of 500 to 1000 mg/m2 BID on each day of a 28 day cycle.
- id
- BG001
- title
- Stratum 2
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 1
- upper Limit
- 17
- value
- 4.4
- group Id
- BG001
- lower Limit
- 1
- upper Limit
- 14
- value
- 6.8
- group Id
- BG002
- lower Limit
- 1
- upper Limit
- 17
- value
- 5.1
- dispersion Type
- FULL_RANGE
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 44
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 55
- title
- Female
- measurements
- group Id
- BG000
- value
- 57
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 85
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 10
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 82
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 114
- title
- White
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 10
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle